ºÚÁÏÍø¹ÙÍø

Grifols USA was established in 2003. Based in Los Angeles, we cover the U.S. market where we offer a comprehensive portfolio of Grifols products and services. The company is one of the largest producers of life-saving plasma medicines and other innovative biopharmaceutical solutions in the world. Our U.S. manufacturing sites are located in Clayton (North Carolina), Los Angeles and Emeryville (California). Grifols also has major operational sites in Denver (Colorado), San Diego and Vista (California), San Marcos and Austin (Texas), Memphis (Tennessee), and Boca Raton (Florida). With a presence in 40 states, we are a key part of Grifols’ world-leading plasma donor-center networks. The company, with more than 13,000 employees in the U.S., engages with the communities we call home by supporting civic, social, and educational programs. Our commitment to patients and donors is at the heart of what we do and inspires us to maintain the highest standards of quality and safety as we deliver on our mission of improving the health and well-being of people around the world.